HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS (HIV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS (HIV) trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield? HIV drug combo may cut cardiovascular risk
Disease control Recruiting nowThis study tests whether adding a drug called fostemsavir to standard HIV treatment can lower the risk of heart disease. Researchers will enroll 150 adults with well-controlled HIV who also have at least one heart risk factor, like high blood pressure or smoking. Participants wil…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New peer support program aims to cut substance abuse and HIV risk in transgender community
Disease control Recruiting nowThis study tests a new mutual-help group called the TLC Program for transgender adults who struggle with substance use or are recently in recovery. The program uses mindfulness and values-based skills from Acceptance and Commitment Therapy (ACT) to improve mental health and reduc…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Illinois Institute of Technology • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New study aims to help HIV patients kick the habit for good
Disease control Recruiting nowThis study tests a smoking cessation program designed specifically for people living with HIV. The goal is to help 500 participants quit smoking using a cost-effective approach that is easy to scale. The program includes nicotine replacement therapy and support, with success meas…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE4 • Sponsor: New York University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New app aims to help HIV patients kick the habit
Disease control Recruiting nowThis study compares two different smartphone apps designed to help people living with HIV quit smoking. All participants will also receive nicotine patches and gum. The goal is to see which app works better at helping people stay smoke-free over 6 months.
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Monthly HIV prevention pill could replace daily dosing
Prevention Recruiting nowThis study tests whether a new pill taken once a month (MK-8527) can prevent HIV-1 infection as well as the standard daily PrEP pill. About 4,390 adults at risk for HIV will participate. The goal is to find a more convenient prevention option that people can take less often.
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 17, 2026 10:42 UTC
-
Monthly HIV prevention pill could replace daily dosing for women
Prevention Recruiting nowThis study tests whether a new monthly pill (MK-8527) is better than the standard daily pill at preventing HIV infection in women. About 4,580 HIV-negative women who are sexually active will take either the monthly pill or a daily PrEP pill for comparison. Researchers will track …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 17, 2026 10:27 UTC
-
Spinal adjustments may ease HIV inflammation, small study hints
Symptom relief Recruiting nowThis pilot study is testing whether chiropractic care can improve quality of life and reduce inflammation in adults with HIV. Researchers will compare a group receiving weekly chiropractic adjustments to a group receiving no treatment. The study aims to see if a larger trial is p…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Tyson Perez, DC, PhD • Aim: Symptom relief
Last updated May 17, 2026 10:27 UTC
-
ER study tests quick video to boost HIV and hepatitis c testing
Knowledge-focused Recruiting nowThis study aims to see if a brief, persuasive message—delivered by video or a counselor—can increase HIV and hepatitis C testing among emergency department patients who initially said no. About 2,000 adults who speak English or Spanish and haven't been tested in the past year wil…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: University of South Florida • Aim: Knowledge-focused
Last updated May 17, 2026 10:28 UTC
-
HIV testing habits under the microscope: new study recruits 1,000 volunteers
Knowledge-focused Recruiting nowThis study is asking 1,000 adults in France about how they choose to get tested for HIV. The goal is to learn which testing methods people prefer, such as doctor prescriptions, free testing centers, or self-tests. This information can help improve national HIV screening efforts.
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Sponsor: Université de Reims Champagne-Ardenne • Aim: Knowledge-focused
Last updated May 17, 2026 10:26 UTC
-
Scientists probe Brain-Immune link in HIV stimulant users to tackle depression
Knowledge-focused Recruiting nowThis study looks at how chronic stress changes brain and immune function in people with HIV who use stimulants. Researchers will use brain scans and interviews to understand these changes, with the goal of finding better ways to treat depression and reduce stimulant use. The stud…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC